Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation ...

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. control; There are no OCU410-related serious adverse events reported across the Pha ...

DelveInsight's House Dust Mite Disease Market Insights report includes a comprehensive understanding of current treatment ...

Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine ...

A new study reveals that genetic technology can identify male infertility causes, enhancing IVF decisions and reducing ...

The UK National Screening Committee’s recent recommendation to introduce prostate cancer screening for men with faulty BRCA ...

UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique genetic signal. This could revolutionize ICU care and prevent thousands of ...

PHILADELPHIA— Black patients and patients from socioeconomically disadvantaged neighborhoods are dramatically under-represented in genetics clinics—often at rates half or less than those of White ...

A study led by the Research Institute of the McGill University Health Center (The Institute) has identified a rare genetic variant in the ODAD4 gene that causes primary ciliary dyskinesia (PCD), a ...

A study led by the Research Institute of the McGill University Health Center (The Institute) has identified a rare genetic variant in the ODAD4 gene that causes primary ciliary dyskinesia (PCD), a ...

Jane Tiller receives funding from a National Health and Medical Research Council Investigator Grant and previously received research funding from the Australian Government Genomics Health Futures ...

Genetic testing is extremely important in prostate cancer, but it’s essential to clarify what we mean. There are two main types: germline testing and somatic testing. Somatic testing can be done on ...